中华微生物学和免疫学杂志
中華微生物學和免疫學雜誌
중화미생물학화면역학잡지
CHINESE JOURNAL OF MICROBIOLOGY AND IMMUNOLOGY
2014年
11期
825-829
,共5页
孙寒晓%胡志刚%曹雅楠%庄文芳%宣彬彬%Igor Maricic%盛慧明
孫寒曉%鬍誌剛%曹雅楠%莊文芳%宣彬彬%Igor Maricic%盛慧明
손한효%호지강%조아남%장문방%선빈빈%Igor Maricic%성혜명
CD8+调节性T细胞%表型%免疫抑制%EAE
CD8+調節性T細胞%錶型%免疫抑製%EAE
CD8+조절성T세포%표형%면역억제%EAE
CD8+regulatory T cell%Phenotype%Immunosuppression%EAE
目的:研究外周CD8αα+TCRαβ+调节性T细胞的表型和免疫调节功能。方法采用流式细胞术分析CD8αα+TCRαβ+T细胞在 C57BL/6J小鼠体内的分布情况,并对其进行了相关表型分析,随后采用anti-CD3抗体刺激,流式微球分析细胞因子分泌格局;采用流式细胞术分选和CFSE标记方法,在体外研究CD8αα+TCRαβ+T细胞调节抑制功能,并采用细胞过继免疫实验观察CD8αα+TCRαβ+T细胞对实验性变态反应性脑脊髓炎( EAE)小鼠模型的保护作用。结果在C57BL/6J小鼠肝脏、脾脏和外周血中存在一群 CD8αα+TCRαβ+T 细胞与CD8αβ+TCRαβ+T细胞相比具有CD25+CD122highCD44highCD62LlowCD69highNK1.1+DX5+记忆效应表型,激活后能迅速产生IL-2,随后产生IFN-γ、TNF-α、IL-4和IL-17A以及微量IL-6和IL-10。体外功能实验表明CD8αα+TCRαβ+T细胞专一性抑制活化CD4+T细胞的分化(P<0.01),体内实验证明该群细胞具有抑制自身活化CD4+T细胞介导的EAE,延缓疾病发展和保护的效果( P<0.01)。结论 CD8αα+TCRαβ+T细胞是体内一群固有的具有免疫调节功能的CD8+调节性T细胞,有望成为细胞治疗新靶点用于自身免疫性等各类疾病。
目的:研究外週CD8αα+TCRαβ+調節性T細胞的錶型和免疫調節功能。方法採用流式細胞術分析CD8αα+TCRαβ+T細胞在 C57BL/6J小鼠體內的分佈情況,併對其進行瞭相關錶型分析,隨後採用anti-CD3抗體刺激,流式微毬分析細胞因子分泌格跼;採用流式細胞術分選和CFSE標記方法,在體外研究CD8αα+TCRαβ+T細胞調節抑製功能,併採用細胞過繼免疫實驗觀察CD8αα+TCRαβ+T細胞對實驗性變態反應性腦脊髓炎( EAE)小鼠模型的保護作用。結果在C57BL/6J小鼠肝髒、脾髒和外週血中存在一群 CD8αα+TCRαβ+T 細胞與CD8αβ+TCRαβ+T細胞相比具有CD25+CD122highCD44highCD62LlowCD69highNK1.1+DX5+記憶效應錶型,激活後能迅速產生IL-2,隨後產生IFN-γ、TNF-α、IL-4和IL-17A以及微量IL-6和IL-10。體外功能實驗錶明CD8αα+TCRαβ+T細胞專一性抑製活化CD4+T細胞的分化(P<0.01),體內實驗證明該群細胞具有抑製自身活化CD4+T細胞介導的EAE,延緩疾病髮展和保護的效果( P<0.01)。結論 CD8αα+TCRαβ+T細胞是體內一群固有的具有免疫調節功能的CD8+調節性T細胞,有望成為細胞治療新靶點用于自身免疫性等各類疾病。
목적:연구외주CD8αα+TCRαβ+조절성T세포적표형화면역조절공능。방법채용류식세포술분석CD8αα+TCRαβ+T세포재 C57BL/6J소서체내적분포정황,병대기진행료상관표형분석,수후채용anti-CD3항체자격,류식미구분석세포인자분비격국;채용류식세포술분선화CFSE표기방법,재체외연구CD8αα+TCRαβ+T세포조절억제공능,병채용세포과계면역실험관찰CD8αα+TCRαβ+T세포대실험성변태반응성뇌척수염( EAE)소서모형적보호작용。결과재C57BL/6J소서간장、비장화외주혈중존재일군 CD8αα+TCRαβ+T 세포여CD8αβ+TCRαβ+T세포상비구유CD25+CD122highCD44highCD62LlowCD69highNK1.1+DX5+기억효응표형,격활후능신속산생IL-2,수후산생IFN-γ、TNF-α、IL-4화IL-17A이급미량IL-6화IL-10。체외공능실험표명CD8αα+TCRαβ+T세포전일성억제활화CD4+T세포적분화(P<0.01),체내실험증명해군세포구유억제자신활화CD4+T세포개도적EAE,연완질병발전화보호적효과( P<0.01)。결론 CD8αα+TCRαβ+T세포시체내일군고유적구유면역조절공능적CD8+조절성T세포,유망성위세포치료신파점용우자신면역성등각류질병。
Objective To investigate the phenotype and the immunoregulatory function of CD8αα+TCRαβ+regulatory T cells in peripheral blood samples from mice.Methods The distribution profile and the phenotype of CD8αα+TCRαβ+regulatory T cells in C57BL/6 mice were detected by flow cytometry.The cytokines released by CD8αα+TCRαβ+regulatory T cells upon the stimulation with anti-CD3 antibody were analyzed by cytometric bead array.The in vitro immunosuppressive activity of CD8αα+TCRαβ+regulatory T cells on activated CD4+T cells was analyzed by using flow cytometry and carboxyfluorescein succinimidyl ester ( CFSE ) .An adoptive cell transfer assay was set up to evaluate the immunoprotective effects of CD8αα+TCRαβ+ regulatory T cells in a mouse model of experimental autoimmune encephalomyelitis ( EAE) .Results CD8αα+TCRαβ+regulatory T cells were detected in liver, spleen and peripheral blood samples collected from na?ve C57BL/6 mice.Compared with CD8αβ+TCRαβ+regulatory T cells, CD8αα+TCRαβ+regulatory T cells showed a memory-activated phenotype of CD25+CD122high CD44high CD62Llow CD69high NK1.1+DX5+.CD8αα+TCRαβ+regulatory T cells could produce IL-2 after 24 hours stimulation with anti-CD3 antibody, followed by producing IFN-γ, TNF-α, IL-4, IL-17A and traces of IL-6 and IL-10. In vitro, CD8αα+TCRαβ+regulatory T cells specifically suppressed the proliferation of activated CD4+T cells ( P<0.01 ).Moreover, they could delay the onset of EAE in mice and reduce clinical score (P<0.01).Conclusion CD8αα+TCRαβ+regulatory T cells were a unique population with immunoregula-tory function, which could be used as a potential therapeutic target in the treatment of autoimmune disease.